Preliminary findings in corneal allograft rejection in patients with keratoconus

American Journal of Ophthalmology

Volumn 135, Issue 4, 2003, Pages 452-460

  Hargrave, Sylvia ^a,b   Chu, Yilin ^a   Mendelblatt, David ^a   Mayhew, Elizabeth ^a   Niederkorn, Jerry ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPY; CELL DENSITY; CLINICAL FEATURE; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DISEASE COURSE; EOSINOPHIL; GRAFT FAILURE; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; KERATOCONUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REOPERATION; STAINING; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CORNEA; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; KERATOCONUS; KERATOPLASTY, PENETRATING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037376822     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)02055-X     Document Type: Article

References (31)

1. Hilgartner H.H.H., Gilbert J.T. Keratoconus successfully treated with organotherapy, radium and shortwave diathermy. Am J Ophthalmol. 20:1937;1032.
2. Gasset A.R., Hinson W.A., Frias J.L. Keratoconus and atopic diseases. Ann Ophthalmol. 10:1978;991-994.
3. Davies P.D., Lobascher D., Menon J.A., Rahi A.H., Ruben M. Immunological studies in keratoconus. Trans Ophthalmol Soc U K. 96:1976;173-178.
4. Harrison R.J., Klouda P.T., Easty D.L., Manku M., Charles J., Stewart C.M. Association between keratoconus and atopy. Br J Ophthalmol. 73:1989;816-822.
5. Rahi A., Davies P., Ruben M., Lobascher D., Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol. 61:1977;761-764.
6. Reinhard T., Moller M., Sundmacher R. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A. Cornea. 18:1999;645-651.
7. Paglen P.G., Fine M., Abbott R.L., Webster R.G. The prognosis for keratoplasty in keratoconus. Ophthalmology. 89:1982;651-654.
8. Metz D.P., Hingorani M., Calder V.L., Buckley R.J., Lightman S.L. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol. 100:1997;817-824.
9. Tepper R.I., Coffman R.L., Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science. 257:1992;548-551.
10. H2 regulation of the immune response to solid organ transplants in the adult . Curr Opin Immunol. 7:1995;632-638.
11. H2 paradigm in transplantation. Curr Opin Immunol. 6:1994;757-764.
12. Chen N., Field E.H. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation. 59:1995;933-941.
13. He Y.G., Ross J., Niederkorn J.Y. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 32:1991;2723-2728.
14. H2. J Exp Med. 181:1995;1869-1874.
15. H2-type response in vitro. J Exp Med. 182:1995;5-13.
16. H2-like effector cells in peripheral tolerance. Transplantation. 53:1992;1281-1294.
17. Goldman M., Moine A.L., Braun M., Flamand V., Abramowicz D. A role for eosinophils in transplant rejection. Trends Immunol. 22:2001;247-251.
18. Steiger J.U., Nickerson P.W., Hermle M., Thiel G., Heim M.H. Interferon-gamma receptor signaling is not required in the effector phase of the alloimmune response. Transplantation. 65:1998;1649-1652.
19. Matesic D., Valujskikh A., Pearlman E., Higgins A.W., Gilliam A.C., Heeger P.S. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. J Immunol. 161:1998;5236-5244.
20. H2 cytokine production and alternate mechanisms of allograft rejection. Transplantation. 59:1995;1155-1161.
21. H2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol. 162:1999;5247-5255.
22. She S.C., Steahly L.P., Moticka E.J. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg. 21:1990;781-785.
23. Hargrave S.L., Taherzadeh S., Hegde S., Niederkorn J. High-risk corneal allografts are capable of stimulating complement dependent cytolytic antibodies. Cornea. 19:2000;521-525.
24. Yamagami S., Kawashima H., Endo H., et al. Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. Transplantation. 66:1998;1504-1510.
25. Sano Y., Osawa H., Sotozono C., Kinoshita S. Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophthalmol Vis Sci. 39:1998;1953-1957.
26. Torres P.F., De Vos A.F., van der Gaag R., Martins B., Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res. 63:1996;453-461.
27. Gould D.S., Auchincloss H. Jr. Direct and indirect recognition the role of MHC antigens in graft rejection . Immunol Today. 20:1999;77-82.
28. Ksander B.R., Sano Y., Streilein J.W. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl Immunol. 4:1996;49-52.
29. Pescovitz M.D., Thistlethwaite J.R. Jr, Auchincloss H. Jr, et al. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med. 160:1984;1495-1508.
30. Sano Y., Ksander B.R., Streilein J.W. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci. 36:1995;2176-2185.
31. VanBuskirk A.M., Wakely M.E., Orosz C.G. Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations. Transplantation. 62:1996;300-302.